Chemical Name:2-[(4-nitrophenyl)diazenyl]-3-oxo-N-phenylbutanamide

CAS.NO:1657-16-5

Synonyms:Kromon Primrose Yellow;Irgalite Yellow 5GL;Hansa Yellow 13G;Recolite Yellow 5G;Eljon Yellow 5G;Irgalite Yellow 5G;Carnelio Yellow 5G;Fast Yellow 11J;Pigment Yellow 5G;Pigment Yellow 4

Molecular Formula:C₁₆H₁₄N₄O₄

Molecular Weight:326.30700

HS Code:2927000090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:527.6ºC at 760mmHg

Density:1.32g/cm3

Index of Refraction:1.628

PSA:116.71000

Exact Mass:326.10200

LogP:3.87100

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Kromon Primrose Yellow chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pigment Yellow 4 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Irgalite Yellow 5GL Use and application,Hansa Yellow 13G technical grade,usp/ep/jp grade.

Related News: The drug, Imfinzi, when added to chemotherapy and the drugmaker��s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said. 2-[(4-nitrophenyl)diazenyl]-3-oxo-N-phenylbutanamide manufacturer A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday. 2-[(4-nitrophenyl)diazenyl]-3-oxo-N-phenylbutanamide supplier The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. 2-[(4-nitrophenyl)diazenyl]-3-oxo-N-phenylbutanamide vendor The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. 2-[(4-nitrophenyl)diazenyl]-3-oxo-N-phenylbutanamide factory The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.